查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1916924

非PVC輸液袋市場按產品類型、材料、銷售和最終用戶分類－全球預測（2026-2032年）

Non-PVC Empty IV Bags Market by Product Type, Material, Capacity, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年非PVC空氣輸液袋市值為3.7194億美元，預計2026年將成長至4.0707億美元，年複合成長率為9.63%，到2032年將達到7.0819億美元。

主要市場統計數據
基準年 2025 3.7194億美元
預計年份：2026年 4.0707億美元
預測年份：2032年 7.0819億美元
複合年成長率 (%) 9.63%

簡明實用的非PVC輸液袋介紹：重點在於材料促進因素、臨床完整性和供應鏈影響

本執行摘要重點概述了非聚氯乙烯（PVC）輸液袋，並闡述了其在現代輸液治療和醫療供應鏈中的作用。由於臨床需求、監管關注和永續性考量，乙烯-醋酸乙烯酯共聚物（EVA）、聚乙烯（PE）和聚丙烯（PP）等非PVC材料正逐漸成為傳統PVC解決方案的替代品。隨著臨床醫生和採購負責人日益關注可萃取物和患者安全，向非PVC材料的轉變正在重塑產品設計、製造流程和檢驗要求。

材料創新、監管壓力、環境問題以及不斷變化的醫療服務模式如何改變非PVC輸液袋生態系統

臨床實務、生產製造和採購的變化正在重塑非聚氯乙烯（PVC）輸液袋的市場模式。首先，材料創新正在加速發展。製造商正在改進乙烯-醋酸乙烯酯共聚物（EVA）、聚乙烯和聚丙烯的配方，以平衡材料的柔軟性、阻隔性能和與滅菌製程的兼容性。這些進步降低了與可萃取物相關的臨床風險，同時實現了更多樣化的輸液袋規格和填充量，最終支持更廣泛的治療方法。

評估美國關稅到2025年對輸液產品籌資策略、供應鏈韌性和供應商關係的下游影響

美國關稅的累積影響將持續到2025年，正在影響非PVC輸液袋價值鏈中的籌資策略、成本結構和供應商關係。關稅調整增加了許多醫療保健採購商進口零件和成品的實際到岸成本，迫使買家和製造商重新評估供應商選擇和採購合約。為此，一些供應商加快了本地化進程，而另一些供應商則專注於提高營運效率和價值工程，以在不違反規定的前提下保持價格競爭力。

深入了解如何將產品類型、材料選擇、終端用戶需求和生產能力考量與臨床和商業性優先事項相匹配。

細分市場分析揭示了製造商和採購商應重點關注的研發和採購領域，以滿足臨床和營運需求。按產品類型分類的細分市場突顯了需求的頻譜，從用於常規輸液的單腔輸液袋到多腔輸液袋（包括三腔系統），後者可實現更複雜的預混合料療法。尤其值得關注的是雙腔輸液袋，本文分析了帶有排氣口和沒有排氣口的兩種設計，這些設計會影響適應症、給藥技術以及與特定輸液器和接頭的兼容性。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和營運要務正在影響製造、採購和合規策略。

區域趨勢將對非PVC輸液袋的生產決策、監管策略和市場推廣方式產生重大影響。在美洲，需求模式正朝著醫院大批量需求和家庭輸液解決方案需求成長並存的方向發展。區域製造商和經銷商越來越重視快速補貨、服務等級協議和合規文件，以滿足買家的期望。供應鏈的韌性至關重要，這促使他們專注於近岸外包機會，並與成熟的區域加工商合作，以縮短前置作業時間並降低關稅風險。

透過材料科學、製造柔軟性以及上市後的監管和臨床支持，使您的公司脫穎而出，滿足多樣化的客戶需求。

主要企業層面洞察凸顯了領先的製造商和供應商如何憑藉其材料專業知識、柔軟性的契約製造和法規支援服務脫穎而出。成功的公司往往會投資於聚合物科學能力和內部測試，以加速乙烯-醋酸乙烯酯共聚物、聚乙烯和聚丙烯解決方案的合格，從而縮短證明其與滅菌工藝兼容性以及記錄可萃取物和可萃取物特性所需的時間。

為製造商和買家提供策略和營運建議，以增強材料檢驗、供應鏈韌性和以客戶為中心的產品系列

針對行業領導者的具體建議著重於使產品開發、供應鏈策略和商業性合作與不斷變化的臨床和採購重點保持一致。首先，應優先進行材料合格項目，檢驗乙烯-醋酸乙烯酯共聚物、聚乙烯和聚丙烯配方，從而獲得清晰的臨床證據和監管文件。投資於標準化測試通訊協定和透明的文件記錄將縮短醫院和門診醫療機構的合格時間。

透過嚴謹的多方法研究途徑，結合相關人員訪談、技術文獻綜述和供應鏈分析，檢驗了具有實務意義的產業洞察。

本分析的調查方法結合了與關鍵相關人員的直接對話、對二手文獻的綜合分析以及跨部門檢驗，以確保提供可靠的實用見解。主要研究內容包括與醫院、門診中心和居家照護機構的採購經理、臨床技術人員和護理人員進行結構化訪談和諮詢，特別關注養老院和私人住宅中的易用性需求。這些訪談最終評估了單腔、雙腔和三腔配置的設備的易用性、容量偏好和臨床適用性。

前瞻性綜合分析重點在於材料權衡、區域採購要求和服務主導的差異化，以推動未來發展。

總之，非聚氯乙烯（PVC）輸液袋處於材料創新、不斷發展的醫療服務模式和日益嚴格的供應鏈監管的交匯點。乙烯-醋酸乙烯酯共聚物（EVA）、聚乙烯和聚丙烯各自具有獨特的性能權衡，這些權衡會影響滅菌策略、可萃取物風險管理和生產過程。產品類型的差異化——從單腔裝置到多腔系統，再到有或沒有排氣口的雙腔設計——能夠實現客製化的臨床解決方案，但也需要謹慎選擇供應商並進行相容性測試。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 非PVC輸液袋市場（依產品類型分類）

  • 單人房
  • 三室型
  • 雙腔型
    • 附通風口
    • 無通風口

9. 非PVC輸液袋市場（依材料分類）

  • 乙烯-醋酸乙烯酯
  • 聚乙烯
  • 聚丙烯

10. 非PVC輸液袋市場（以銷量計）

  • 250～500ml
  • 500毫升或以上
  • 250毫升或以下
    • 100～250ml
    • 100毫升或以下

第11章 非PVC輸液袋市場（依最終用戶分類）

  • 門診治療中心
  • 居家醫療
    • 輔助生活設施
    • 私人住宅
  • 醫院

12. 各地區非PVC輸液袋市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 非PVC輸液袋市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國非PVC輸液袋市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章美國非PVC輸液袋市場

第17章：中國非PVC輸液袋市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Angiplast Pvt. Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Haemotronic SpA
  • ICU Medical, Inc.
  • JW Life Science Corp.
  • Kraton Corporation
  • Medline Industries, Inc.
  • Otsuka Pharmaceutical Factory, Inc.
  • PolyCine GmbH
  • RENOLIT SE
  • Shanghai Solve Care Co., Ltd.
  • Sippex IV Bag Manufacturing Co., Ltd.
  • Technoflex SAS
Product Code: MRR-AE420CB153FA

The Non-PVC Empty IV Bags Market was valued at USD 371.94 million in 2025 and is projected to grow to USD 407.07 million in 2026, with a CAGR of 9.63%, reaching USD 708.19 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 371.94 million
Estimated Year [2026] USD 407.07 million
Forecast Year [2032] USD 708.19 million
CAGR (%) 9.63%

A concise and action-oriented introduction to non-PVC empty IV bags highlighting material drivers, clinical alignment, and supply chain implications

This executive summary presents a focused introduction to non-PVC empty IV bags, framing their role in contemporary infusion therapy and healthcare supply chains. Non-PVC materials such as ethylene vinyl acetate, polyethylene, and polypropylene have emerged as alternatives to traditional PVC solutions, driven by clinical concerns, regulatory attention, and sustainability considerations. As clinicians and procurement professionals increasingly scrutinize materials for leachables, extractables, and patient safety, the shift toward non-PVC formats is reshaping product design, manufacturing processes, and validation requirements.

The landscape is also influenced by device configuration choices that align with therapy complexity and user needs. Product types range from single chamber bags for standard infusions to multi-chamber systems that enable separation of components until point of use; within these options, two chamber formats may be offered with or without vent ports to meet application-specific requirements. Capacity choices affect logistics and care delivery models, including smaller formats that support home infusion and larger volumes tailored to inpatient workflows. End users encompass ambulatory care centers, hospitals, and home care settings, with the latter including assisted living facilities and private residences.

Taken together, these dynamics underline the importance of integrating clinical performance, material science, and supply chain resilience when evaluating non-PVC empty IV bag options. This introduction establishes the foundational considerations that inform the deeper analysis in the subsequent sections of the report.

How material innovation, regulatory pressures, environmental concerns, and shifting care delivery models are transforming the non-PVC empty IV bag ecosystem

Transformative shifts are reshaping the non-PVC empty IV bag landscape across clinical practice, manufacturing, and procurement. First, material innovation has accelerated: manufacturers are refining ethylene vinyl acetate, polyethylene, and polypropylene formulations to balance flexibility, barrier properties, and compatibility with sterilization processes. These advances reduce clinical risk related to leachables while enabling a wider range of bag geometries and fill volumes, which in turn supports more diverse therapy regimens.

Second, regulatory and environmental pressures are prompting reassessment of single-use device lifecycles and disposal strategies. Healthcare systems are increasingly evaluating the downstream environmental footprint of infusion products alongside traditional safety metrics, pushing suppliers to document life-cycle impacts and to pursue recyclable or lower-impact materials without compromising sterility and performance. Meanwhile, supply chain strategies are undergoing a tactical pivot: organizations are prioritizing supplier diversification, regional manufacturing capacity, and transparent raw material sourcing to mitigate disruption risks.

Third, care delivery models are evolving. The growth of home care and ambulatory services is shifting demand toward smaller capacity formats and user-friendly designs that support non-clinical caregivers in assisted living facilities and private residences. At the same time, hospitals continue to require a range of capacities, from up to 100 mL formats to above 500 mL systems, and configurations that support compounding or multi-component therapies. These converging trends are driving product differentiation, requiring manufacturers to align development roadmaps with clinical workflows and procurement priorities.

Assessing the downstream effects of U.S. tariff measures through 2025 on procurement strategies, supply chain resilience, and supplier relationships in infusion products

The cumulative impact of United States tariff actions implemented through 2025 has influenced sourcing strategies, cost structures, and supplier relationships within the non-PVC empty IV bag value chain. Tariff changes have increased the effective landed cost of imported components and finished goods for many healthcare purchasers, prompting buyers and manufacturers to revisit supplier footprints and procurement contracts. In response, some suppliers accelerated regionalization efforts, while others focused on improving operational efficiencies and value engineering to maintain competitive pricing without compromising compliance.

Additionally, the tariff environment heightened the emphasis on transparency in the upstream supply chain. Procurement teams intensified efforts to map raw material origins for ethylene vinyl acetate, polyethylene, and polypropylene resins, seeking to understand exposure to trade measures and to negotiate supply agreements that include contingency clauses. Manufacturers facing elevated import costs also revisited inventory strategies and payment terms, balancing capital tied up in safety stocks against the risk of short-notice supply interruptions.

Clinically, the tariff-driven shifts reinforced the imperative for robust supplier qualification processes. Hospitals, ambulatory centers, and home care providers demanded clearer traceability, quality documentation, and localized support capabilities. Collectively, these adjustments illustrate how trade policy variables can catalyze longer-term structural changes in sourcing approaches, vertical integration considerations, and collaborative risk-sharing between buyers and manufacturers.

Deep segmentation-driven insights that align product type, material selection, end-user needs, and capacity considerations to clinical and commercial priorities

Segmentation insights reveal where manufacturers and buyers should concentrate development and procurement efforts to align with clinical and operational needs. Product type segmentation highlights the demand spectrum from single chamber bags intended for routine infusions to multi-chamber formats, including three chamber systems that enable more complex, pre-mixed therapies. Two chamber configurations deserve particular attention because they are studied across designs with and without vent ports; the presence or absence of a vent port influences application suitability, administration technique, and compatibility with specific IV sets and connectors.

Material segmentation frames performance expectations and manufacturing considerations. Ethylene vinyl acetate offers a balance of flexibility and chemical compatibility, polyethylene brings favorable cost and processability characteristics, and polypropylene is chosen for its higher temperature tolerance and strength. Each polymer family imposes unique requirements on sterilization validation, extractables and leachables testing, and packaging design, so material selection must align with intended clinical use and sterilization pathways.

End user segmentation underscores differing procurement and product requirements across settings. Ambulatory care centers typically prioritize ease of handling and throughput, hospitals require a broad capacity range and compatibility with compounding workflows, and home care prioritizes portability and caregiver usability, with subsegments including assisted living facilities and private residences. Capacity segmentation further clarifies logistics and usage patterns: categories ranging from up to 100 mL and 100-250 mL within the up to 250 mL band, to 250-500 mL and above 500 mL formats, shape inventory planning, device handling protocols, and infusion regimen suitability. Integrating these segmentation lenses supports targeted product development and differentiated market strategies.

Regional dynamics and operational imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape manufacturing, procurement, and compliance strategies

Regional dynamics materially influence manufacturing decisions, regulatory strategies, and go-to-market approaches for non-PVC empty IV bags. In the Americas, demand patterns favor a mix of high-volume hospital requirements and a growing appetite for home infusion solutions; regional manufacturers and distributors increasingly emphasize rapid replenishment, service-level agreements, and compliance documentation to meet purchaser expectations. Supply chain resilience is a priority, prompting interest in nearshoring opportunities and partnerships with established regional converters to reduce lead times and mitigate tariff exposure.

Across Europe, the Middle East & Africa, regulatory harmonization, environmental reporting requirements, and waste management policies are significant drivers of product design and facility investment. Suppliers that can demonstrate validated pathways for recyclable or lower-impact materials, alongside robust quality systems and clinical evidence supporting safety, gain strategic advantage in procurement dialogs. Local manufacturing capacity and logistical networks also determine how quickly new non-PVC formulations can be scaled into hospital and ambulatory channels.

In the Asia-Pacific region, manufacturers are both major producers of polymer resins and important converters of medical-grade films and films-to-bag products. This concentration of upstream capability supports competitive cost structures but also introduces sensitivity to global trade dynamics. Buyers and suppliers operating in Asia-Pacific prioritize supplier audits, adherence to international quality standards, and manufacturing flexibility to respond to diverse regional clinical practices and capacity requirements. Taken together, regional considerations require tailored commercial approaches and risk management practices that reflect local regulations, distribution systems, and clinical use patterns.

Corporate differentiation through material science, manufacturing flexibility, and post-market regulatory and clinical support to meet diverse buyer needs

Key company-level insights center on how leading manufacturers and suppliers differentiate through material expertise, contract manufacturing flexibility, and regulatory support services. Successful companies tend to invest in polymer science capabilities and in-house testing to accelerate qualification of ethylene vinyl acetate, polyethylene, and polypropylene solutions, thereby shortening the time required to demonstrate compatibility with sterilization processes and to document extractables and leachables profiles.

Operationally, firms that have diversified their converter networks and established regional manufacturing nodes show greater agility in responding to tariff-induced cost shifts and localized demand surges. These companies often offer modular production lines that can handle single chamber, two chamber, and three chamber formats, including variations for two chamber systems with and without vent ports. Such flexibility enables rapid changeovers to support customer-specific pack-outs and labeling requirements.

Commercially, leaders provide robust post-market support, including clinical liaison services, quality documentation packages, and training resources tailored to hospitals, ambulatory care centers, and home care providers. They also design capacity assortments spanning up to 100 mL formats to above 500 mL options to address the diverse needs of end users. In addition, partnerships with raw material suppliers and investments in traceability systems strengthen sourcing resilience and enhance customer confidence during supplier qualification processes.

Strategic and operational recommendations for manufacturers and buyers to strengthen material validation, supply resilience, and customer-focused product portfolios

Actionable recommendations for industry leaders focus on aligning product development, supply chain strategy, and commercial engagement to evolving clinical and procurement priorities. First, prioritize material qualification programs that validate ethylene vinyl acetate, polyethylene, and polypropylene formulations across sterilization cycles and extractables testing, enabling clear clinical evidence and regulatory dossiers. Investing in standardized testing protocols and transparent documentation will shorten qualification timelines for hospitals and ambulatory providers.

Second, build supply chain resilience by expanding regional manufacturing capacity and diversifying converters to reduce exposure to tariff volatility. Establishing contingency agreements with upstream resin suppliers and developing flexible inventory policies will reduce the risk of disruptive shortages while preserving working capital. Third, tailor product portfolios to end-user segmentation: design ergonomic, smaller capacity formats and simplified administration for home care and assisted living settings while maintaining higher-capacity, compounding-friendly formats for hospital environments. Include options for two chamber designs both with and without vent ports to address administration preferences.

Fourth, enhance commercial value by offering comprehensive supplier qualification packages, clinical education resources, and localized service capabilities. Fifth, incorporate environmental performance metrics into product development and communication strategies, documenting life-cycle impacts and disposal pathways to meet buyer sustainability expectations. Collectively, these steps will fortify market position and align offerings with the operational realities of modern healthcare delivery.

A rigorous multi-method research approach combining stakeholder interviews, technical literature review, and supply chain mapping to validate practical industry insights

The research methodology underpinning this analysis combines primary stakeholder engagement, secondary literature synthesis, and cross-functional validation to ensure robust and actionable insights. Primary inputs included structured interviews and consultations with procurement leaders, clinical engineers, and nursing staff across hospitals, ambulatory centers, and home care providers, with particular attention to usability requirements for assisted living facilities and private residences. These engagements informed assessments of device handling, volume preferences, and clinical compatibility for single chamber, two chamber, and three chamber formats.

Secondary investigation focused on technical literature, regulatory guidance, and materials science publications that address polymer behavior, sterilization compatibility, and extractables and leachables considerations for ethylene vinyl acetate, polyethylene, and polypropylene. Manufacturer technical bulletins and quality documentation were reviewed to understand manufacturing processes, sterilization methods, and packaging considerations. Cross-validation exercises compared primary stakeholder feedback with secondary findings to identify convergent themes and to surface operational trade-offs.

Finally, the analysis incorporated supply chain mapping and risk assessment techniques to evaluate regional manufacturing capacity, tariff exposure, and logistical constraints. Quality control of the study was maintained through iterative reviews with subject-matter experts in polymer chemistry, clinical infusion practice, and regulatory affairs to ensure that conclusions are grounded in practical, evidence-based considerations.

A forward-looking synthesis emphasizing material trade-offs, regional sourcing imperatives, and service-led differentiation for future readiness

In conclusion, non-PVC empty IV bags are at the intersection of materials innovation, evolving care delivery models, and heightened supply chain scrutiny. Ethylene vinyl acetate, polyethylene, and polypropylene each present distinct performance trade-offs that influence sterilization strategies, extractables risk management, and manufacturing processes. Product type differentiation-from single chamber units to multi-chamber systems and two chamber designs with or without vent ports-enables tailored clinical solutions but also requires meticulous supplier qualification and compatibility testing.

Regional dynamics and tariff developments through 2025 have accelerated the need for procurement agility and localized manufacturing options, while environmental and regulatory expectations are increasing the importance of lifecycle transparency and waste management plans. End users across ambulatory care centers, hospitals, assisted living facilities, and private residences demand different form factors and service levels, so companies that align material science capabilities with flexible manufacturing and strong post-market support will be best positioned to meet those needs.

Overall, the path forward requires coordinated investment in material validation, supply chain diversification, and customer-centered commercial practices to deliver safe, compliant, and operationally effective non-PVC infusion solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Non-PVC Empty IV Bags Market, by Product Type

  • 8.1. Single Chamber
  • 8.2. Three Chamber
  • 8.3. Two Chamber
    • 8.3.1. With Vent Port
    • 8.3.2. Without Vent Port

9. Non-PVC Empty IV Bags Market, by Material

  • 9.1. Ethylene Vinyl Acetate
  • 9.2. Polyethylene
  • 9.3. Polypropylene

10. Non-PVC Empty IV Bags Market, by Capacity

  • 10.1. 250-500 ML
  • 10.2. Above 500 ML
  • 10.3. Up to 250 ML
    • 10.3.1. 100-250 ML
    • 10.3.2. Up to 100 ML

11. Non-PVC Empty IV Bags Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Home Care
    • 11.2.1. Assisted Living Facilities
    • 11.2.2. Private Residences
  • 11.3. Hospital

12. Non-PVC Empty IV Bags Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Non-PVC Empty IV Bags Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Non-PVC Empty IV Bags Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Non-PVC Empty IV Bags Market

16. China Non-PVC Empty IV Bags Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Angiplast Pvt. Ltd.
  • 17.6. B. Braun Melsungen AG
  • 17.7. Baxter International Inc.
  • 17.8. Fresenius Kabi AG
  • 17.9. Haemotronic SpA
  • 17.10. ICU Medical, Inc.
  • 17.11. JW Life Science Corp.
  • 17.12. Kraton Corporation
  • 17.13. Medline Industries, Inc.
  • 17.14. Otsuka Pharmaceutical Factory, Inc.
  • 17.15. PolyCine GmbH
  • 17.16. RENOLIT SE
  • 17.17. Shanghai Solve Care Co., Ltd.
  • 17.18. Sippex IV Bag Manufacturing Co., Ltd.
  • 17.19. Technoflex SAS

LIST OF FIGURES

  • FIGURE 1. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NON-PVC EMPTY IV BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NON-PVC EMPTY IV BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY THREE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY THREE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY THREE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY WITH VENT PORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY WITH VENT PORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY WITH VENT PORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY WITHOUT VENT PORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY WITHOUT VENT PORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY WITHOUT VENT PORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY 250-500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY 250-500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY 250-500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ABOVE 500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ABOVE 500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ABOVE 500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY 100-250 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY 100-250 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY 100-250 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 100 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 100 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 100 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRIVATE RESIDENCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRIVATE RESIDENCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRIVATE RESIDENCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 137. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 140. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 142. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 143. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 161. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 164. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 166. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 167. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 172. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 173. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 174. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 175. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)